Rebecca Taub
2017
In 2017, Rebecca Taub earned a total compensation of $1.1M as Chief Medical Officer, Executive Vice President, Research & Development at Synta Pharmaceuticals, a 34% decrease compared to previous year.
Compensation breakdown
Bonus | $247,900 |
---|---|
Salary | $370,000 |
Stock Awards | $473,337 |
Other | $558 |
Total | $1,091,795 |
Taub received $473.3K in stock awards, accounting for 43% of the total pay in 2017.
Taub also received $247.9K in bonus, $370K in salary and $558 in other compensation.
Rankings
In 2017, Rebecca Taub's compensation ranked 8,570th out of 14,666 executives tracked by ExecPay. In other words, Taub earned more than 41.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,570 | 42nd |
Manufacturing | 3,251 | 44th |
Chemicals And Allied Products | 1,085 | 48th |
Drugs | 859 | 50th |
Pharmaceutical Preparations | 670 | 50th |
Taub's colleagues
We found two more compensation records of executives who worked with Rebecca Taub at Synta Pharmaceuticals in 2017.